KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Minority Interest: 2012-2013

Historic Minority Interest for Acadia Pharmaceuticals (ACAD) over the last 1 years, with Sep 2013 value amounting to $10.7 million.

  • Acadia Pharmaceuticals' Minority Interest was N/A to $10.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $10.7 million, marking a year-over-year change of. This contributed to the annual value of $17.7 million for FY2012, which is N/A change from last year.
  • As of Q3 2013, Acadia Pharmaceuticals' Minority Interest stood at $10.7 million, which was down 39.64% from $17.7 million recorded in Q2 2013.
  • In the past 5 years, Acadia Pharmaceuticals' Minority Interest registered a high of $17.7 million during Q4 2012, and its lowest value of $10.7 million during Q3 2013.
  • For the 2-year period, Acadia Pharmaceuticals' Minority Interest averaged around $15.9 million, with its median value being $17.7 million (2013).